Limits...
Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China

View Article: PubMed Central - PubMed

ABSTRACT

The aim of the study is to investigate the prevalence of high-risk human papillomavirus (hr-HPV) genotypes among Han women with high-grade cervical lesions in Beijing, China.

Cervical cell specimens from patients with histopathologically confirmed cervical lesions at 7 hospitals in Beijing were examined with a validated HPV kit for 13 hr-HPV genotypes during the study period. The patients were divided into a low-grade cervical lesions group (cervical intraepithelial neoplasia grade 1, CIN1) and a high-grade cervical lesions group (CIN2+, including cervical intraepithelial neoplasia grade 2, CIN2; cervical intraepithelial neoplasia grade 3, CIN3; squamous cervical cancer, SCC; and adenocarcinoma of the cervix, ACC) based on the histopathology results.

A total of 2817 eligible patients were enrolled, including 610 cases identified as CIN1 and 2207 as CIN2+. The hr-HPV positive rates in the CIN1 and CIN2+ groups were 78.2% (477/610) and 93.3% (2060/2207), respectively. The most frequently detected genotypes were HPV16, 58, 52 and18 in the CIN1 group and HPV16, 58, 33, and 52 in the CIN2+ group, in descending order of prevalence. In addition, the prevalence of HPV18 among the patients with ACC was 28.6% (14/49), significantly >7.2% (54/752) prevalence among the SCC patients (P < 0.001). Additionally, significantly more women in the CIN2+ group had multiple infections compared with those in the CIN1 group (38.1% and 24.9%, respectively; P < 0.001). However, as the cervical lesion grade increased, the prevalence of multiple hr-HPV infections gradually deceased to 44.2% in the CIN2 patients, 36.7% in the CIN3 patients, and 35.3% in the cervical cancer (CC) patients, which included SCC and ACC patients. In cases of multiple hr-HPV infections in the CIN2+ group, double infections accounted for ∼76.6%, and HPV16+58, HPV16+52, and HPV16+18 were the most common combinations, in descending order. The most frequent combination for triple infections was HPV16+58+31, with a rate of 4.2%. The highest positive rate occurred in the ≤24 year-old group for all types of cervical lesions.

The prevalence of HPV genotypes in the targeted population with high-grade cervical lesions differs from that of other countries. This information could be helpful for the prevention of CC in Beijing, China.

No MeSH data available.


Related in: MedlinePlus

Distribution of high-risk human papillomavirus (hr-HPV) in CIN1 (cervical intraepithelial neoplasia grade 1), CIN2 (cervical intraepithelial neoplasia grade 2), CIN3 (cervical intraepithelial neoplasia grade 3), SCC (squamous cervical cancer), ACC (adenocarcinoma of the cervix), and CIN2+ (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients. ACC = adenocarcinoma of the cervix, CIN1 = cervical intraepithelial neoplasia grade 1, CIN2 = cervical intraepithelial neoplasia grade 2, CIN2+ = (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients, CIN3 = cervical intraepithelial neoplasia grade 3, hr-HPV = high-risk human papillomavirus, SCC = squamous cervical cancer.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4998280&req=5

Figure 1: Distribution of high-risk human papillomavirus (hr-HPV) in CIN1 (cervical intraepithelial neoplasia grade 1), CIN2 (cervical intraepithelial neoplasia grade 2), CIN3 (cervical intraepithelial neoplasia grade 3), SCC (squamous cervical cancer), ACC (adenocarcinoma of the cervix), and CIN2+ (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients. ACC = adenocarcinoma of the cervix, CIN1 = cervical intraepithelial neoplasia grade 1, CIN2 = cervical intraepithelial neoplasia grade 2, CIN2+ = (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients, CIN3 = cervical intraepithelial neoplasia grade 3, hr-HPV = high-risk human papillomavirus, SCC = squamous cervical cancer.

Mentions: The distribution of hr-HPV genotypes according to cervical lesions is shown in Figure 1. The 5 most common genotypes in patients with CIN1 were HPV16, 58, 52, 18, and 39. In the CIN2+ group, HPV16 was the most common genotype, accounting for 60.1% (1326/2207), followed by HPV58 (27.3%, 602/2207), HPV33 (10.0%, 221/2207), HPV52 (8.5%, 188/2207), and HPV18 (7.7%, 170/2207). The 5 most common hr-HPV genotypes were HPV16, 58, 52, 31, and 39 in CIN2; HPV16, 58, 33, 52, and 18 in CIN3; HPV16, 58, 33, 18, and 52 in SCC; and HPV16, 58, 18, 33, and 59 in ACC, in descending order. In addition, the prevalence of HPV18 in ACC was 28.6% (14/49), significantly >7.2% (54/752) prevalence in SCC (P < 0.001). A comparison of the prevalence of the 13 types of hr-HPV in women with high-grade cervical lesions in the present study and that reported in global statistics5 is presented in Table 1, which shows that worldwide, HPV16, 31, 33, 58, and 18 were the 5 most common genotypes in women with CIN2/CIN3; HPV16, 18, 33, 45, and 31 were the 5 most common genotypes in women with CC; and HPV16, 18, 31, 33, and 58 were the 5 most common genotypes in women with CIN2+, all in descending order.


Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China
Distribution of high-risk human papillomavirus (hr-HPV) in CIN1 (cervical intraepithelial neoplasia grade 1), CIN2 (cervical intraepithelial neoplasia grade 2), CIN3 (cervical intraepithelial neoplasia grade 3), SCC (squamous cervical cancer), ACC (adenocarcinoma of the cervix), and CIN2+ (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients. ACC = adenocarcinoma of the cervix, CIN1 = cervical intraepithelial neoplasia grade 1, CIN2 = cervical intraepithelial neoplasia grade 2, CIN2+ = (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients, CIN3 = cervical intraepithelial neoplasia grade 3, hr-HPV = high-risk human papillomavirus, SCC = squamous cervical cancer.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4998280&req=5

Figure 1: Distribution of high-risk human papillomavirus (hr-HPV) in CIN1 (cervical intraepithelial neoplasia grade 1), CIN2 (cervical intraepithelial neoplasia grade 2), CIN3 (cervical intraepithelial neoplasia grade 3), SCC (squamous cervical cancer), ACC (adenocarcinoma of the cervix), and CIN2+ (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients. ACC = adenocarcinoma of the cervix, CIN1 = cervical intraepithelial neoplasia grade 1, CIN2 = cervical intraepithelial neoplasia grade 2, CIN2+ = (high-grade cervical lesions, including CIN2, CIN3, SCC, and ACC) patients, CIN3 = cervical intraepithelial neoplasia grade 3, hr-HPV = high-risk human papillomavirus, SCC = squamous cervical cancer.
Mentions: The distribution of hr-HPV genotypes according to cervical lesions is shown in Figure 1. The 5 most common genotypes in patients with CIN1 were HPV16, 58, 52, 18, and 39. In the CIN2+ group, HPV16 was the most common genotype, accounting for 60.1% (1326/2207), followed by HPV58 (27.3%, 602/2207), HPV33 (10.0%, 221/2207), HPV52 (8.5%, 188/2207), and HPV18 (7.7%, 170/2207). The 5 most common hr-HPV genotypes were HPV16, 58, 52, 31, and 39 in CIN2; HPV16, 58, 33, 52, and 18 in CIN3; HPV16, 58, 33, 18, and 52 in SCC; and HPV16, 58, 18, 33, and 59 in ACC, in descending order. In addition, the prevalence of HPV18 in ACC was 28.6% (14/49), significantly >7.2% (54/752) prevalence in SCC (P < 0.001). A comparison of the prevalence of the 13 types of hr-HPV in women with high-grade cervical lesions in the present study and that reported in global statistics5 is presented in Table 1, which shows that worldwide, HPV16, 31, 33, 58, and 18 were the 5 most common genotypes in women with CIN2/CIN3; HPV16, 18, 33, 45, and 31 were the 5 most common genotypes in women with CC; and HPV16, 18, 31, 33, and 58 were the 5 most common genotypes in women with CIN2+, all in descending order.

View Article: PubMed Central - PubMed

ABSTRACT

The aim of the study is to investigate the prevalence of high-risk human papillomavirus (hr-HPV) genotypes among Han women with high-grade cervical lesions in Beijing, China.

Cervical cell specimens from patients with histopathologically confirmed cervical lesions at 7 hospitals in Beijing were examined with a validated HPV kit for 13 hr-HPV genotypes during the study period. The patients were divided into a low-grade cervical lesions group (cervical intraepithelial neoplasia grade 1, CIN1) and a high-grade cervical lesions group (CIN2+, including cervical intraepithelial neoplasia grade 2, CIN2; cervical intraepithelial neoplasia grade 3, CIN3; squamous cervical cancer, SCC; and adenocarcinoma of the cervix, ACC) based on the histopathology results.

A total of 2817 eligible patients were enrolled, including 610 cases identified as CIN1 and 2207 as CIN2+. The hr-HPV positive rates in the CIN1 and CIN2+ groups were 78.2% (477/610) and 93.3% (2060/2207), respectively. The most frequently detected genotypes were HPV16, 58, 52 and18 in the CIN1 group and HPV16, 58, 33, and 52 in the CIN2+ group, in descending order of prevalence. In addition, the prevalence of HPV18 among the patients with ACC was 28.6% (14/49), significantly &gt;7.2% (54/752) prevalence among the SCC patients (P&#8202;&lt;&#8202;0.001). Additionally, significantly more women in the CIN2+ group had multiple infections compared with those in the CIN1 group (38.1% and 24.9%, respectively; P&#8202;&lt;&#8202;0.001). However, as the cervical lesion grade increased, the prevalence of multiple hr-HPV infections gradually deceased to 44.2% in the CIN2 patients, 36.7% in the CIN3 patients, and 35.3% in the cervical cancer (CC) patients, which included SCC and ACC patients. In cases of multiple hr-HPV infections in the CIN2+ group, double infections accounted for &sim;76.6%, and HPV16+58, HPV16+52, and HPV16+18 were the most common combinations, in descending order. The most frequent combination for triple infections was HPV16+58+31, with a rate of 4.2%. The highest positive rate occurred in the &le;24 year-old group for all types of cervical lesions.

The prevalence of HPV genotypes in the targeted population with high-grade cervical lesions differs from that of other countries. This information could be helpful for the prevention of CC in Beijing, China.

No MeSH data available.


Related in: MedlinePlus